NCT06959680

Brief Summary

The primary aim of our research is to evaluate the positive effects of exercise and kinesiotaping on the thoracic kyphosis angle in young adults between the ages of 18-45 with a thoracic kyphosis angle of 40 degrees and above. Secondary aims are to investigate the effects of kinesiotaping on dynamic and static balance, pain, and quality of life in patients with thoracic hyperkyphosis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

April 29, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 6, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 29, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 29, 2026

Completed
Last Updated

September 12, 2025

Status Verified

September 1, 2025

Enrollment Period

9 months

First QC Date

April 28, 2025

Last Update Submit

September 5, 2025

Conditions

Keywords

BalancePostural KyphosisKinesio taping

Outcome Measures

Primary Outcomes (1)

  • Thoracic hyperkyphosis angle (Kyphosis Angle Measurement with Flexicurve)

    They will be performed at the beginning of the study, at the end of treatment (1st month) and 1 month after the end of treatment (2nd month). Kyphosis index will be calculated with the formula: (TL/TW) x 100. Higher indices will indicate higher degrees of kyphosis. All measurements will be performed by two different specialists, repeated 2 times each and averaged. (How to measure is explained in detail in the 'detailed description' section).

    9 months

Secondary Outcomes (5)

  • Static and Dynamic Balance Measurement with Biodex Device

    9 months

  • Vas (Visual Analog Scale) Scoring

    9 months

  • Berg Balance Scale (Turkish)

    9 months

  • SRS-22 (Turkish)

    9 months

  • International Physical Activity Questionnaire (Short) (IPAQ)

    9 months

Study Arms (3)

Group 1 Exercise

ACTIVE COMPARATOR

Group 1 participants will receive exercise therapy alone.

Other: Exercise

Group 2 Exercise and Kinesiotaping

ACTIVE COMPARATOR

Group 2 participants will receive exercise and kinesiotaping treatment.

Other: Exercise and Kinesiotaping

Group 3 Exercise and Shamtaping

SHAM COMPARATOR

Group 3 participants will receive exercise and shamtaping treatment.

Other: exercise and sham taping

Interventions

Exercise and Kinesiotaping

Group 2 Exercise and Kinesiotaping

only exercise will be performed without any band treatment

Group 1 Exercise

exercise and sham banding (banding without tension with plaster)

Group 3 Exercise and Shamtaping

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Being between the ages of 18-45
  • Among the patients who applied to the physical medicine and rehabilitation outpatient clinic with poor posture or nonspecific back pain, the kyphosis angle was measured as ≥ 40 on the thoracic lateral radiograph
  • Being literate
  • Agreeing to participate in the research

You may not qualify if:

  • Patients younger than 18 years and older than 45 years
  • Spinal deformity, Scheuermann disease, disc herniation
  • Previous spine surgery and trauma
  • Neuromuscular, peripheral neuropathic disease
  • Pregnant and postmenopausal women
  • Vertigo disease (central or peripheral cause)
  • Use of medication that may cause dizziness (in the last 3 months)
  • Defect of vision
  • Presence of physical deformity or additional disease that will prevent exercise
  • Active skin disease in the area where tape will be applied

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Marmara University Faculty of Medicine

Istanbul, Turkey (Türkiye)

RECRUITING

Sultan 2.Abdülhamid Han Training and Research Hospital

Istanbul, Üsküdar, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Feyza Nur Yücel, Specialist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Controlled Randomized Single-Blind Prospective Cohort One group does not know whether the other group received taping treatment. The physiotherapist also does not know whether a participant received taping therapy. The physiotherapist only teaches the participants exercises
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: There are 3 groups of participants in the study Group 1 participants will receive exercise therapy alone. Group 2 participants will receive exercise and kinesiotaping treatment. Group 3 participants will receive exercise and shamtaping treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 28, 2025

First Posted

May 6, 2025

Study Start

April 29, 2025

Primary Completion

January 29, 2026

Study Completion

January 29, 2026

Last Updated

September 12, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations